{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:25:05Z","timestamp":1790630705214,"version":"4.1.0"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,10,31]],"date-time":"2015-10-31T00:00:00Z","timestamp":1446249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00296-015-3387-x","type":"journal-article","created":{"date-parts":[[2015,10,31]],"date-time":"2015-10-31T10:50:50Z","timestamp":1446288650000},"page":"469-482","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Focal bone involvement in inflammatory arthritis: the role of IL17"],"prefix":"10.1007","volume":"36","author":[{"given":"Maurizio","family":"Rossini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ombretta","family":"Viapiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvano","family":"Adami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Idolazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Fracassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,31]]},"reference":[{"key":"3387_CR1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/jbmr.5650100402","volume":"10","author":"S Adami","year":"1995","unstructured":"Adami S, Kanis JA (1995) Assessment of involutional bone loss: methodological and conceptual problems. J Bone Miner Res 10:511\u2013517. doi: 10.1002\/jbmr.5650100402","journal-title":"J Bone Miner Res"},{"key":"3387_CR2","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1056\/NEJMra053077","volume":"354","author":"E Seeman","year":"2006","unstructured":"Seeman E, Delmas PD (2006) Bone quality\u2014the material and structural basis of bone strength and fragility. N Engl J Med 354:2250\u20132261. doi: 10.1056\/NEJMra053077","journal-title":"N Engl J Med"},{"key":"3387_CR3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.beem.2008.07.006","volume":"22","author":"TJ Martin","year":"2008","unstructured":"Martin TJ, Seeman E (2008) Bone remodelling: its local regulation and the emergence of bone fragility. Best Pract Res Clin Endocrinol Metab 22:701\u2013722. doi: 10.1016\/j.beem.2008.07.006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"3387_CR4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1474-9726.2011.00669.x","volume":"10","author":"M Kassem","year":"2011","unstructured":"Kassem M, Marie PJ (2011) Senescence-associated intrinsic mechanisms of osteoblast dysfunctions. Aging Cell 10:191\u2013197. doi: 10.1111\/j.1474-9726.2011.00669.x","journal-title":"Aging Cell"},{"key":"3387_CR5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1210\/jc.2010-2113","volume":"96","author":"PJ Marie","year":"2011","unstructured":"Marie PJ, Kassem M (2011) Extrinsic mechanisms involved in age related defective bone formation. J Clin Endocrinol Metab 96:600\u2013609. doi: 10.1210\/jc.2010-2113","journal-title":"J Clin Endocrinol Metab"},{"key":"3387_CR6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337\u2013342. doi: 10.1038\/nature01658","journal-title":"Nature"},{"key":"3387_CR7","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1210\/endo-123-5-2600","volume":"123","author":"N Takahashi","year":"1988","unstructured":"Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM, Martin TJ, Suda T (1988) Osteoblastic cells are involved in osteoclast formation. Endocrinology 123:2600\u20132602. doi: 10.1210\/endo-123-5-2600","journal-title":"Endocrinology"},{"key":"3387_CR8","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/endo.139.3.5837","volume":"139","author":"H Yasuda","year":"1998","unstructured":"Yasuda H, Shima N, Nakagawa N et al (1998) Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG\/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139:1329\u20131337. doi: 10.1210\/endo.139.3.5837","journal-title":"Endocrinology"},{"key":"3387_CR9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL et al (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165\u2013176. doi: 10.1016\/S0092-8674(00)81569-X","journal-title":"Cell"},{"key":"3387_CR10","doi-asserted-by":"crossref","first-page":"25190","DOI":"10.1074\/jbc.272.40.25190","volume":"272","author":"BR Wong","year":"1997","unstructured":"Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, Kalachikov S, Cayani E, Bartlett FS 3rd, Frankel WN, Lee SY, Choi Y (1997) TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 272:25190\u201325194. doi: 10.1074\/jbc.272.40.25190","journal-title":"J Biol Chem"},{"key":"3387_CR11","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1210\/en.2007-0270","volume":"148","author":"R Baron","year":"2007","unstructured":"Baron R, Rawadi G (2007) Minireview: targeting the Wnt\/\u03b2-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 148:2635\u20132643. doi: 10.1210\/en.2007-0270","journal-title":"Endocrinology"},{"key":"3387_CR12","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra067395","volume":"357","author":"E Canalis","year":"2007","unstructured":"Canalis E, Giustina A, Bilezikian JP (2007) Mechanisms of anabolic therapies for osteoporosis. N Engl J Med 357:905\u2013906. doi: 10.1056\/NEJMra067395","journal-title":"N Engl J Med"},{"key":"3387_CR13","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1242\/jcs.02883","volume":"119","author":"GJ Spencer","year":"2006","unstructured":"Spencer GJ, Utting JC, Etheridge SL, Arnett TR, Genever PG (2006) Wnt signaling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro. J Cell Sci 119:1283\u20131296. doi: 10.1242\/jcs.02883","journal-title":"J Cell Sci"},{"key":"3387_CR14","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","volume":"8","author":"DA Glass 2nd","year":"2005","unstructured":"Glass DA 2nd, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA, Karsenty G (2005) Canonical WNT signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8:751\u2013764. doi: 10.1016\/j.devcel.2005.02.017","journal-title":"Dev Cell"},{"key":"3387_CR15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00223-013-9749-z","volume":"93","author":"M Rossini","year":"2013","unstructured":"Rossini M, Gatti D, Adami S (2013) Involvement of WNT\/\u03b2-catenin signaling in the treatment of osteoporosis. Calcif Tissue Int 93:121\u2013132. doi: 10.1007\/s00223-013-9749-z","journal-title":"Calcif Tissue Int"},{"key":"3387_CR16","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bone.2006.03.017","volume":"39","author":"J Li","year":"2006","unstructured":"Li J, Sarosi I, Cattley RC et al (2006) Dkk1- mediated inhibition of Wnt signaling in bone results in osteopenia. Bone 39:754\u2013766. doi: 10.1016\/j.bone.2006.03.017","journal-title":"Bone"},{"key":"3387_CR17","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","volume":"349","author":"E Tian","year":"2003","unstructured":"Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, Shaughnessy JD Jr (2003) The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 349:2483\u20132494. doi: 10.1056\/NEJMoa030847","journal-title":"N Engl J Med"},{"key":"3387_CR18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nature02040","volume":"425","author":"LM Calvi","year":"2003","unstructured":"Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT (2003) Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425:841\u2013846. doi: 10.1038\/nature02040","journal-title":"Nature"},{"key":"3387_CR19","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1084\/jem.20101890","volume":"208","author":"K Miyamoto","year":"2011","unstructured":"Miyamoto K, Yoshida S, Kawasumi M et al (2011) Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization. J Exp Med 208:2175\u20132181. doi: 10.1084\/jem.20101890","journal-title":"J Exp Med"},{"key":"3387_CR20","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/annrheumdis-2011-201075","volume":"72","author":"S Finzel","year":"2013","unstructured":"Finzel S, Rech J, Schmidt S, Engelke K, Englbrecht M, Schett G (2013) Interleukin-6 receptor blockade induces limited repair of bone erosions in rheumatoid arthritis: a micro CT study. Ann Rheum Dis 72:396\u2013400. doi: 10.1136\/annrheumdis-2011-201075","journal-title":"Ann Rheum Dis"},{"key":"3387_CR21","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/ard.2010.148395","volume":"70","author":"S Finzel","year":"2011","unstructured":"Finzel S, Rech J, Schmidt S, Engelke K, Englbrecht M, Stach C, Schett G (2011) Repair of bone erosions in rheumatoid arthritis treated with tumour necrosis factor inhibitors is based on bone apposition at the base of the erosion. Ann Rheum Dis 70:1587\u20131593. doi: 10.1136\/ard.2010.148395","journal-title":"Ann Rheum Dis"},{"key":"3387_CR22","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/art.1780270902","volume":"27","author":"M Bromley","year":"1984","unstructured":"Bromley M, Woolley DE (1984) Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint. Arthritis Rheum 27:968\u2013975. doi: 10.1002\/art.1780270902","journal-title":"Arthritis Rheum"},{"key":"3387_CR23","first-page":"943","volume":"152","author":"EM Gravallese","year":"1998","unstructured":"Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR (1998) Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 152:943\u2013951","journal-title":"Am J Pathol"},{"key":"3387_CR24","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","volume":"402","author":"YY Kong","year":"1999","unstructured":"Kong YY, Feige U, Sarosi I et al (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402:304\u2013309. doi: 10.1038\/46303","journal-title":"Nature"},{"key":"3387_CR25","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0002-9440(10)63016-7","volume":"159","author":"AR Pettit","year":"2001","unstructured":"Pettit AR, Ji H, von Stechow D, M\u00fcller R, Goldring SR, Choi Y, Benoist C, Gravallese EM (2001) TRANCE\/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 159:1689\u20131699. doi: 10.1016\/S0002-9440(10)63016-7","journal-title":"Am J Pathol"},{"key":"3387_CR26","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1002\/art.23943","volume":"58","author":"S Herman","year":"2008","unstructured":"Herman S, Mueller R, Kroenke G, Zerina J, Redlich K, Hueber AJ, Gelse H, Neumann E, M\u00fcller-Ladner U, Schett G (2008) Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis. Arthritis Rheum 58:3041\u20133050. doi: 10.1002\/art.23943","journal-title":"Arthritis Rheum"},{"issue":"5","key":"3387_CR27","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/art.21824","volume":"54","author":"SJ Jarrett","year":"2006","unstructured":"Jarrett SJ, Conaghan PG, Sloan VS, Papanastasiou P, Ortmann CE, O\u2019Connor PJ, Grainger AJ, Emery P (2006) Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis. Arthritis Rheum 54(5):1410\u20131414. doi: 10.1002\/art.21824","journal-title":"Arthritis Rheum"},{"key":"3387_CR28","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/ard.2010.142539","volume":"70","author":"F McQueen","year":"2011","unstructured":"McQueen F, Lloyd R, Doyle A, Robinson E, Lobo M, Exeter M, Taylor WJ, Jones P, Reid IR, Dalbeth N (2011) Zoledronic acid does not reduce MRI erosive progression in PsA but may suppress bone oedema: the Zoledronic Acid in Psoriatic Arthritis (ZAPA) Study. Ann Rheum Dis 70:1091\u20131094. doi: 10.1136\/ard.2010.142539","journal-title":"Ann Rheum Dis"},{"key":"3387_CR29","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/art.23417","volume":"58","author":"SB Cohen","year":"2008","unstructured":"Cohen SB, Dore RK, Lane NE, Ory PA, Peterfy CG, Sharp JT, van der Heijde D, Zhou L, Tsuji W, Newmark R (2008) Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis Rheum 58:1299\u20131309. doi: 10.1002\/art.23417","journal-title":"Arthritis Rheum"},{"key":"3387_CR30","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/acr.20004","volume":"62","author":"A Deodhar","year":"2010","unstructured":"Deodhar A, Dore RK, Mandel D, Schechtman J, Shergy W, Trapp R, Ory PA, Peterfy CG, Fuerst T, Wang H, Zhou L, Tsuji W, Newmark R (2010) Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 62:569\u2013574. doi: 10.1002\/acr.20004","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3387_CR31","unstructured":"U.S. Food and Drug Administration (2013) Drug approvals and databases. Denosumab. http:\/\/www.fda.gov\/Drugs\/InformationOnDrugs\/ApprovedDrugs\/ucm356667.htm?source=govdelivery . Accessed 11 Oct 2014"},{"key":"3387_CR32","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10875-009-9316-6","volume":"29","author":"T Nakashima","year":"2009","unstructured":"Nakashima T, Takayanagi H (2009) Osteoimmunology: crosstalk between the immune and bone systems. J Clin Immunol 29:555\u2013567. doi: 10.1007\/s10875-009-9316-6","journal-title":"J Clin Immunol"},{"key":"3387_CR33","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nrrheum.2012.167","volume":"8","author":"H Takayanagi","year":"2012","unstructured":"Takayanagi H (2012) New developments in osteoimmunology. Nat Rev Rheumatol 8:684\u2013689. doi: 10.1038\/nrrheum.2012.167","journal-title":"Nat Rev Rheumatol"},{"key":"3387_CR34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/bbrc.1999.1623","volume":"265","author":"NJ Horwood","year":"1999","unstructured":"Horwood NJ, Kartsogiannis V, Quinn JM, Romas E, Martin TJ, Gillespie MT (1999) Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun 265:144\u2013150. doi: 10.1006\/bbrc.1999.1623","journal-title":"Biochem Biophys Res Commun"},{"key":"3387_CR35","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1172\/JCI200316069","volume":"111","author":"CT Ritchlin","year":"2003","unstructured":"Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM (2003) Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 111:821\u2013831. doi: 10.1172\/JCI200316069","journal-title":"J Clin Invest"},{"key":"3387_CR36","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1186\/ar2915","volume":"12","author":"YG Chiu","year":"2010","unstructured":"Chiu YG, Shao T, Feng C, Mensah KA, Thullen M, Schwarz EM, Ritchlin CT (2010) CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis. Arthritis Res Ther 12:R14. doi: 10.1186\/ar2915","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"3387_CR37","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1359\/jbmr.2003.18.6.984","volume":"18","author":"D Mirosavljevic","year":"2003","unstructured":"Mirosavljevic D, Quinn JM, Elliott J, Horwood NJ, Martin TJ, Gillespie MT (2003) T-cells mediate an inhibitory effect of interleukin-4 on osteoclastogenesis. J Bone Miner Res 18(6):984\u2013993. doi: 10.1359\/jbmr.2003.18.6.984","journal-title":"J Bone Miner Res"},{"key":"3387_CR38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1359\/JBMR.0301233","volume":"19","author":"P Li","year":"2004","unstructured":"Li P, Schwarz EM, O\u2019Keefe RJ, Ma L, Boyce BF, Xing L (2004) RANK signaling is not required for TNF\u03b1-mediated increase in CD11 OC precursors but is essential for mature OC formation in TNF\u03b1-mediated inflammatory arthritis. J Bone Miner Res 19:207\u2013213. doi: 10.1359\/JBMR.0301233","journal-title":"J Bone Miner Res"},{"key":"3387_CR39","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1006\/cyto.2000.0681","volume":"12","author":"M Chabaud","year":"2000","unstructured":"Chabaud M, Garnero P, Dayer JM, Guerne PA, Fossiez F, Miossec P (2000) Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis. Cytokine 12:1092\u20131099. doi: 10.1006\/cyto.2000.0681","journal-title":"Cytokine"},{"key":"3387_CR40","first-page":"515","volume":"35","author":"S Agarwal","year":"2008","unstructured":"Agarwal S, Misra R, Aggarwal A (2008) Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases. J Rheumatol 35:515\u2013519","journal-title":"J Rheumatol"},{"key":"3387_CR41","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123\u20131132. doi: 10.1038\/ni1254","journal-title":"Nat Immunol"},{"key":"3387_CR42","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrd3794","volume":"11","author":"P Miossec","year":"2012","unstructured":"Miossec P, Kolls JK (2012) Targeting IL17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov 11:763\u2013776. doi: 10.1038\/nrd3794","journal-title":"Nat Rev Drug Discov"},{"key":"3387_CR43","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature11981","volume":"496","author":"N Yosef","year":"2013","unstructured":"Yosef N, Shalek AK, Gaublomme JT et al (2013) Dynamic regulatory network controlling TH17 cell differentiation. Nature 496:461\u2013468. doi: 10.1038\/nature11981","journal-title":"Nature"},{"key":"3387_CR44","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","volume":"6","author":"H Park","year":"2005","unstructured":"Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6:1133\u20131141. doi: 10.1038\/ni1261","journal-title":"Nat Immunol"},{"key":"3387_CR45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1749-6632.2010.05825.x","volume":"1217","author":"Y Hu","year":"2011","unstructured":"Hu Y, Shen F, Crellin NK, Ouyang W (2011) The IL17 pathway as a major therapeutic target in autoimmune diseases. Ann NY Acad Sci 1217:60\u201376. doi: 10.1111\/j.1749-6632.2010.05825.x","journal-title":"Ann NY Acad Sci"},{"key":"3387_CR46","doi-asserted-by":"crossref","first-page":"7525","DOI":"10.4049\/jimmunol.178.12.7525","volume":"178","author":"W Sato","year":"2007","unstructured":"Sato W, Aranami T, Yamamura T (2007) Cutting edge: human Th17 cells are identified as bearing CCR2+CCR5\u2212 phenotype. J Immunol 178:7525\u20137529. doi: 10.4049\/jimmunol.178.12.7525","journal-title":"J Immunol"},{"key":"3387_CR47","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nri2761","volume":"10","author":"AC Chan","year":"2012","unstructured":"Chan AC, Carter PJ (2012) Therapeutic antibodies for autoimmunity and inflammation. Nat Rev Immunol 10:301\u2013316. doi: 10.1038\/nri2761","journal-title":"Nat Rev Immunol"},{"key":"3387_CR48","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1136\/ard.2011.153312","volume":"70","author":"L Yeo","year":"2011","unstructured":"Yeo L, Toellner KM, Salmon M, Filer A, Buckley CD, Raza K, Scheel-Toellner D (2011) Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis. Ann Rheum Dis 70:2022\u20132028. doi: 10.1136\/ard.2011.153312","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3387_CR49","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/annrheumdis-2011-200198","volume":"71","author":"MJ Boumans","year":"2012","unstructured":"Boumans MJ, Thurlings RM, Yeo L, Scheel-Toellner D, Vos K, Gerlag DM, Tak PP (2012) Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis. Ann Rheum Dis 71(1):108\u2013113. doi: 10.1136\/annrheumdis-2011-200198","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"3387_CR50","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/annrheumdis-2013-204116","volume":"74","author":"L Yeo","year":"2015","unstructured":"Yeo L, Lom H, Juarez M, Snow M, Buckley CD, Filer A, Raza K, Scheel-Toellner D (2015) Expression of FcRL4 defines a pro-inflammatory, RANKL-producing B cell subset in rheumatoid arthritis. Ann Rheum Dis 74(5):928\u2013935. doi: 10.1136\/annrheumdis-2013-204116","journal-title":"Ann Rheum Dis"},{"key":"3387_CR51","doi-asserted-by":"crossref","first-page":"29851","DOI":"10.1074\/jbc.M112.377945","volume":"287","author":"M Onal","year":"2012","unstructured":"Onal M, Xiong J, Chen X, Thostenson JD, Almeida M, Manolagas SC, O\u2019Brien CA (2012) RANKL expression by B lymphocytes contributes to ovariectomy-induced bone loss. J Biol Chem 287:29851\u201329860. doi: 10.1074\/jbc.M112.377945","journal-title":"J Biol Chem"},{"key":"3387_CR52","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI60975","volume":"122","author":"U Harre","year":"2012","unstructured":"Harre U, Georgess D, Bang H et al (2012) Induction of Osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 122:1791\u20131802. doi: 10.1172\/JCI60975","journal-title":"J Clin Invest"},{"key":"3387_CR53","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4049\/jimmunol.161.1.409","volume":"161","author":"M Chabaud","year":"1998","unstructured":"Chabaud M, Fossiez F, Taupin JL, Miossec P (1998) Enhancing effect of IL17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol 161:409\u2013414","journal-title":"J Immunol"},{"key":"3387_CR54","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.4049\/jimmunol.150.12.5445","volume":"150","author":"E Rouvier","year":"1993","unstructured":"Rouvier E, Luciani MF, Matt\u00e9i MG, Denizot F, Golstein P (1993) CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol 150:5445\u20135556","journal-title":"J Immunol"},{"key":"3387_CR55","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","volume":"42","author":"M Chabaud","year":"1999","unstructured":"Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, Miossec P (1999) Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42:963\u2013970. doi: 10.1002\/1529-0131(199905)42:5<963:AID-ANR15>3.0.CO;2-E","journal-title":"Arthritis Rheum"},{"key":"3387_CR56","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/1529-0131(200106)44:6<1293::AID-ART221>3.0.CO;2-T","volume":"44","author":"M Chabaud","year":"2001","unstructured":"Chabaud M, Miossec P (2001) The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model. Arthritis Rheum 44:1293\u20131303. doi: 10.1002\/1529-0131(200106)44:6<1293:AID-ART221>3.0.CO;2-T","journal-title":"Arthritis Rheum"},{"key":"3387_CR57","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.4049\/jimmunol.167.2.1004","volume":"167","author":"E Lubberts","year":"2001","unstructured":"Lubberts E, Joosten LA, Oppers B, van den Bersselaar L, Coenen-de Roo CJ, Kolls JK, Schwarzenberger P, van de Loo FA, van den Berg WB (2001) IL-1-independent role of IL17 in synovial inflammation and joint destruction during collagen-induced arthritis. J Immunol 167:1004\u20131013. doi: 10.4049\/jimmunol.167.2.1004","journal-title":"J Immunol"},{"key":"3387_CR58","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s40259-014-0098-x","volume":"28","author":"S Adami","year":"2014","unstructured":"Adami S, Cavani A, Rossi F, Girolomoni G (2014) The role of interleukin-17A in psoriatic disease. BioDrugs 28:487\u2013497. doi: 10.1007\/s40259-014-0098-x","journal-title":"BioDrugs"},{"key":"3387_CR59","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.4049\/jimmunol.164.5.2832","volume":"164","author":"M Ziolkowska","year":"2000","unstructured":"Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, Chwalinska-Sadowska H, Maslinski W (2000) High levels of IL17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL17 production via cyclosporine A-sensitive mechanism. J Immunol 164:2832\u20132838. doi: 10.4049\/jimmunol.164.5.2832","journal-title":"J Immunol"},{"key":"3387_CR60","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1002\/1529-0131(200109)44:9<2176::AID-ART371>3.0.CO;2-4","volume":"44","author":"Y Katz","year":"2001","unstructured":"Katz Y, Nadiv O, Beer Y (2001) Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukin 1, 6 and 8 in skin and synovial fibroblasts: a possible role as a \u201cfine-tuning cytokine\u201d in inflammation process. Arthritis Rheum 44:2176\u20132184. doi: 10.1002\/1529-0131(200109)44:9<2176:AID-ART371>3.0.CO;2-4","journal-title":"Arthritis Rheum"},{"key":"3387_CR61","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.4049\/jimmunol.160.7.3513","volume":"160","author":"DV Jovanovic","year":"1998","unstructured":"Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M, Mineau F, Pelletier JP (1998) IL17 stimulates the production and expression of proinflammatory cytokines, IL-1beta and TNF alpha, by human macrophages. J Immunol 160:3513\u20133521","journal-title":"J Immunol"},{"key":"3387_CR62","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1074\/jbc.M308809200","volume":"279","author":"MJ Ruddy","year":"2004","unstructured":"Ruddy MJ, Wong GC, Liu XK, Yamamoto H, Kasayama S, Kirkwood KL, Gaffen SL (2004) Functional cooperation between interleukin-17 and tumor necrosis factor-\u03b1 is mediated by CCAAT\/enhancer binding protein family members. J Biol Chem 279:2559\u20132567. doi: 10.1074\/jbc.M308809200","journal-title":"J Biol Chem"},{"issue":"11","key":"3387_CR63","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1084\/jem.20072707","volume":"205","author":"CA Notley","year":"2008","unstructured":"Notley CA, Inglis JJ, Alzabin S, McCann FE, McNamee KE, Williams RO (2008) Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells. J Exp Med 205(11):2491\u20132497. doi: 10.1084\/jem.20072707","journal-title":"J Exp Med"},{"key":"3387_CR64","author":"DN Hull","year":"2015","unstructured":"Hull DN, Williams RO, Pathan E, Alzabin S, Abraham S, Taylor PC (2015) Anti-tumour necrosis factor treatment increases circulating T helper type 17 cells similarly in different types of inflammatory arthritis. Clin Exp Immunol. doi: 10.1111\/cei.12626","journal-title":"Clin Exp Immunol"},{"key":"3387_CR65","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.coi.2006.09.008","volume":"18","author":"K Kikly","year":"2006","unstructured":"Kikly K, Liu L, Na S, Sedgwick JD (2006) The IL-23\/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr Opin Immunol 18:670\u2013675. doi: 10.1016\/j.coi.2006.09.008","journal-title":"Curr Opin Immunol"},{"key":"3387_CR66","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12016-012-8307-1","volume":"44","author":"SP Raychaudhuri","year":"2013","unstructured":"Raychaudhuri SP (2013) Role of IL17 in psoriasis and psoriatic arthritis. Clin Rev Allerg Immunol 44:183\u20131893. doi: 10.1007\/s12016-012-8307-1","journal-title":"Clin Rev Allerg Immunol"},{"key":"3387_CR67","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.cyto.2008.07.017","volume":"43","author":"SL Gaffen","year":"2008","unstructured":"Gaffen SL (2008) An overview of IL17 function and signalling. Cytokine 43:402\u2013407. doi: 10.1016\/j.cyto.2008.07.017","journal-title":"Cytokine"},{"key":"3387_CR68","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/annrheumdis-2012-202646","volume":"73","author":"IB McInnes","year":"2014","unstructured":"McInnes IB, Sieper J, Braun J, Emery P, van der Heijde D, Isaacs JD, Dahmen G, Wollenhaupt J, Schulze-Koops H, Kogan J, Ma S, Schumacher MM, Bertolino AP, Hueber W, Tak PP (2014) Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial. Ann Rheum Dis 73:349\u2013356. doi: 10.1136\/annrheumdis-2012-202646","journal-title":"Ann Rheum Dis"},{"key":"3387_CR69","author":"IB McInnes","year":"2015","unstructured":"McInnes IB, Mease PJ, Kirkham B, Kavanaugh A, Ritchlin CT, Rahman P, van der Heijde D, Landew\u00e9 R, Conaghan PG, Gottlieb AB, Richards H, Pricop L, Ligozio G, Patekar M, Mpofu S, FUTURE 2 Study Group (2015) Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. doi: 10.1016\/S0140-6736(15)61134-5","journal-title":"Lancet"},{"key":"3387_CR70","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3899\/jrheum.130637","volume":"41","author":"MC Genovese","year":"2014","unstructured":"Genovese MC, Durez P, Richards HB, Supronik J, Dokoupilova E, Aelion JA, Lee SH, Codding CE, Kellner H, Ikawa T, Hugot S, Ligozio G, Mpofu S (2014) One-year efficacy and safety results of secukinumab in patients with rheumatoid arthritis:phase II, dose-finding, double-blind, randomized, placebo-controlled study. J Rheumatol 41:414\u2013421. doi: 10.3899\/jrheum.130637","journal-title":"J Rheumatol"},{"key":"3387_CR71","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ng.873","volume":"43","author":"DM Evans","year":"2011","unstructured":"Evans DM, Spencer CC, Pointon JJ et al (2011) Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 43:761\u2013767. doi: 10.1038\/ng.873","journal-title":"Nat Genet"},{"key":"3387_CR72","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ng.2667","volume":"45","author":"A Cortes","year":"2013","unstructured":"Cortes A, Hadler J, Pointon JP et al (2013) Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet 45:730\u2013738. doi: 10.1038\/ng.2667","journal-title":"Nat Genet"},{"key":"3387_CR73","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock JP, Joyce-Shaikh B, Turner SP, Chao CC, Sathe M, Grein J, Gorman DM, Bowman EP, McClanahan TK, Yearley JH, Eberl G, Buckley CD, Kastelein RA, Pierce RH, Laface DM, Cua DJ (2012) IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+CD3+CD4-CD8- entheseal resident T cells. Nat Med 18:1069\u20131076. doi: 10.1038\/nm.2817","journal-title":"Nat Med"},{"key":"3387_CR74","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/art.34423","volume":"64","author":"M Ruutu","year":"2012","unstructured":"Ruutu M, Thomas G, Steck R, Degli-Esposti MA, Zinkernagel MS, Alexander K, Velasco J, Strutton G, Tran A, Benham H, Rehaume L, Wilson RJ, Kikly K, Davies J, Pettit AR, Brown MA, McGuckin MA, Thomas R (2012) \u03b2-glucan triggers spondylarthritis and Crohn\u2019s disease-like ileitis in SKG mice. Arthritis Rheum 64:2211\u20132222. doi: 10.1002\/art.34423","journal-title":"Arthritis Rheum"},{"key":"3387_CR75","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/ar3370","volume":"13","author":"H Appel","year":"2011","unstructured":"Appel H, Maier R, Wu P, Scheer R, Hempfing A, Kayser R, Thiel A, Radbruch A, Loddenkemper C, Sieper J (2011) Analysis of IL17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response. Arthritis Res Ther 13:R95. doi: 10.1186\/ar3370","journal-title":"Arthritis Res Ther"},{"key":"3387_CR76","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/art.33396","volume":"64","author":"T Noordenbos","year":"2012","unstructured":"Noordenbos T, Yeremenko N, Gofita I, van de Sande M, Tak PP, Ca\u0148ete JD, Baeten D (2012) Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis. Arthritis Rheum 64:99\u2013109. doi: 10.1002\/art.33396","journal-title":"Arthritis Rheum"},{"key":"3387_CR77","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","volume":"382","author":"D Baeten","year":"2013","unstructured":"Baeten D, Baraliakos X, Braun J et al (2013) Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. Lancet 382:1705\u20131713. doi: 10.1016\/S0140-6736(13)61134-4","journal-title":"Lancet"},{"key":"3387_CR78","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/BOR.0b013e328303204b","volume":"20","author":"G Layh-Schmitt","year":"2008","unstructured":"Layh-Schmitt G, Colbert RA (2008) The interleukin-23\/interleukin-17 axis in spondyloarthritis. Curr Opin Rheumatol 20:392\u2013397. doi: 10.1097\/BOR.0b013e328303204b","journal-title":"Curr Opin Rheumatol"},{"key":"3387_CR79","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jbspin.2006.11.005","volume":"74","author":"D Wendling","year":"2007","unstructured":"Wendling D, Cedoz JP, Racadot E, Dumoulin G (2007) Serum IL17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis. Joint Bone Spine 74:304\u2013305. doi: 10.1016\/j.jbspin.2006.11.005","journal-title":"Joint Bone Spine"},{"key":"3387_CR80","first-page":"2285","volume":"34","author":"R Singh","year":"2007","unstructured":"Singh R, Aggarwal A, Misra R (2007) Th1\/Th17 cytokine profiles in patients with reactive arthritis\/undifferentiated spondyloarthropathy. J Rheumatol 34:2285\u20132290","journal-title":"J Rheumatol"},{"key":"3387_CR81","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.3899\/jrheum.100146","volume":"37","author":"H Shen","year":"2010","unstructured":"Shen H, Goodall JC, Hill Gaston JS (2010) Frequency and phenotype of T helper 17 cells in peripheral blood and synovial fluid of patients with reactive arthritis. J Rheumatol 37:2096\u20132099","journal-title":"J Rheumatol"},{"key":"3387_CR82","doi-asserted-by":"crossref","first-page":"e31000","DOI":"10.1371\/journal.pone.0031000","volume":"7","author":"L Zhang","year":"2012","unstructured":"Zhang L, Li YG, Li YH, Qi L, Liu XG, Yuan CZ, Hu NW, Ma DX, Li ZF, Yang Q, Li W, Li JM (2012) Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis. PLoS ONE 7:e31000. doi: 10.1371\/journal.pone.0031000","journal-title":"PLoS ONE"},{"key":"3387_CR83","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/art.33507","volume":"64","author":"TJ Kenna","year":"2012","unstructured":"Kenna TJ, Davidson SI, Duan R, Bradbury LA, McFarlane J, Smith M, Weedon H, Street S, Thomas R, Thomas GP, Brown MA (2012) Enrichment of circulating interleukin-17\u2013secreting interleukin-23 receptor\u2013positive \u03b3\/\u03b4 T cells in patients with active ankylosing spondylitis. Arthritis Rheum 64:1420\u20131429. doi: 10.1002\/art.33507","journal-title":"Arthritis Rheum"},{"key":"3387_CR84","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4049\/jimmunol.180.1.655","volume":"180","author":"S Zrioual","year":"2008","unstructured":"Zrioual S, Toh ML, Tournadre A, Zhou Y, Cazalis MA, Pachot A, Miossec V, Miossec P (2008) IL17RA and IL17RC receptors are essential for IL17A-induced ELR\u00a0+\u00a0CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood. J Immunol 180:655\u2013663. doi: 10.4049\/jimmunol.180.1.655","journal-title":"J Immunol"},{"key":"3387_CR85","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cyto.2007.11.013","volume":"41","author":"F Shen","year":"2008","unstructured":"Shen F, Gaffen SL (2008) Structure\u2013function relationships in the IL17 receptor: implications for signal transduction and therapy. Cytokine 41:92\u2013104. doi: 10.1016\/j.cyto.2007.11.013","journal-title":"Cytokine"},{"key":"3387_CR86","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","volume":"203","author":"K Sato","year":"2006","unstructured":"Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ, Takayanagi H (2006) Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203:2673\u20132682. doi: 10.1084\/jem.20061775","journal-title":"J Exp Med"},{"key":"3387_CR87","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ni1496","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F (2007) Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8:942\u2013949. doi: 10.1038\/ni1496","journal-title":"Nat Immunol"},{"key":"3387_CR88","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S8756-3282(01)00682-2","volume":"30","author":"E Romas","year":"2002","unstructured":"Romas E, Gillespie MT, Martin TJ (2002) Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 30:340\u2013346. doi: 10.1016\/S8756-3282(01)00682-2","journal-title":"Bone"},{"key":"3387_CR89","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI5703","volume":"103","author":"S Kotake","year":"1999","unstructured":"Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin TJ, Suda T (1999) IL17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103:1345\u20131352. doi: 10.1172\/JCI5703","journal-title":"J Clin Invest"},{"key":"3387_CR90","doi-asserted-by":"crossref","first-page":"e26342","DOI":"10.1371\/journal.pone.0026342","volume":"6","author":"CD Sadik","year":"2011","unstructured":"Sadik CD, Kim ND, Alekseeva E, Luster AD (2011) IL17RA signaling amplifies antibody-induced arthritis. PLoS ONE 6:e26342. doi: 10.1371\/journal.pone.0026342","journal-title":"PLoS ONE"},{"key":"3387_CR91","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10456-011-9227-z","volume":"14","author":"SR Pickens","year":"2011","unstructured":"Pickens SR, Chamberlain ND, Volin MV, Gonzalez M, Pope RM, Mandelin AM 2nd, Kolls JK, Shahrara S (2011) Anti-CXCL5 therapy ameliorates IL17-induced arthritis by decreasing joint vascularization. Angiogenesis 14:443\u2013455. doi: 10.1007\/s10456-011-9227-z","journal-title":"Angiogenesis"},{"key":"3387_CR92","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1002\/art.30418","volume":"63","author":"MI Koenders","year":"2011","unstructured":"Koenders MI, Marijnissen RJ, Devesa I, Lubberts E, Joosten LA, Roth J, van Lent PL, van de Loo FA, van den Berg WB (2011) Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1 beta, and matrix metallo proteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis. Arthritis Rheum 63:2329\u20132339. doi: 10.1002\/art.30418","journal-title":"Arthritis Rheum"},{"key":"3387_CR93","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF02684010","volume":"51","author":"E Lubberts","year":"2002","unstructured":"Lubberts E, Joosten LA, van de Loo FA, Schwarzenberger P, Kolls J, van den Berg WB (2002) Overexpression of IL17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction. Inflamm Res 51:102\u2013104","journal-title":"Inflamm Res"},{"key":"3387_CR94","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/art.37762","volume":"65","author":"D Balani","year":"2013","unstructured":"Balani D, Aeberli D, Hofstetter W, Seitz M (2013) Interleukin-17A stimulates granulocyte-macrophage colony-stimulating factor release by murine osteoblasts in the presence of 1,25-dihydroxyvitamin D(3) and inhibits murine osteoclast development in vitro. Arthritis Rheum 65:436\u2013446. doi: 10.1002\/art.37762","journal-title":"Arthritis Rheum"},{"key":"3387_CR95","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","volume":"13","author":"D Diarra","year":"2007","unstructured":"Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen J, Hoffmann M, Scheinecker C, van der Heide D, Landewe R, Lacey D, Richards WG, Schett G (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13:156\u2013163. doi: 10.1038\/nm1538","journal-title":"Nat Med"},{"key":"3387_CR96","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1365-2184.2011.00769.x","volume":"44","author":"H Huang","year":"2011","unstructured":"Huang H, Zhao N, Xu X, Xu Y, Li S, Zhang J, Yang P (2011) Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells. Cell Prolif 44:420\u2013427. doi: 10.1111\/j.1365-2184.2011.00769.x","journal-title":"Cell Prolif"},{"key":"3387_CR97","first-page":"425","volume":"5","author":"B Osta","year":"2014","unstructured":"Osta B, Lavocat F, Eljaafari A, Miossec P (2014) Effects of interleukin-17A on osteogenic differentiation of isolated human mesenchymal stem cells. Front Immunol 5:425. doi: 10.3389\/fimmu.2014.00425","journal-title":"Front Immunol"},{"key":"3387_CR98","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaci.2008.10.031","volume":"123","author":"K Eyerich","year":"2009","unstructured":"Eyerich K, Pennino D, Scarponi C, Foerster S, Nasorri F, Behrendt H, Ring J, Traidl-Hoffmann C, Albanesi C, Cavani A (2009) IL17 in atopic eczema: linking allergenspecific adaptive and microbial-triggered innate immune response. J Allergy Clin Immunol 123:59\u201366. doi: 10.1016\/j.jaci.2008.10.031","journal-title":"J Allergy Clin Immunol"},{"key":"3387_CR99","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.194.4.519","volume":"194","author":"P Ye","year":"2001","unstructured":"Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W, Zhang P, Zhang J, Shellito JE, Bagby GJ, Nelson S, Charrier K, Peschon JJ, Kolls JK (2001) Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colonystimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194:519\u2013527. doi: 10.1084\/jem.194.4.519","journal-title":"J Exp Med"},{"key":"3387_CR100","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.immuni.2009.09.014","volume":"31","author":"N Martin-Orozco","year":"2009","unstructured":"Martin-Orozco N, Muranski P, Chung Y, Yang XO, Yamazaki T, Lu S, Hwu P, Restifo NP, Overwijk WW, Dong C (2009) T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 31:787\u2013798. doi: 10.1016\/j.immuni.2009.09.014","journal-title":"Immunity"},{"key":"3387_CR101","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/jre.12169","volume":"49","author":"VP Parachuru","year":"2014","unstructured":"Parachuru VP, Coates DE, Milne TJ, Hussaini HM, Rich AM, Seymour GJ (2014) Forkhead box P3-positive regulatory T-cells and interleukin 17-positive T-helper 17 cells in chronic inflammatory periodontal disease. J Periodontal Res 49:817\u2013826. doi: 10.1111\/jre.12169","journal-title":"J Periodontal Res"},{"key":"3387_CR102","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/art.38229","volume":"66","author":"OB Corneth","year":"2014","unstructured":"Corneth OB, Mus AM, Asmawidjaja PS, Klein Wolterink RG, van Nimwegen M, Brem MD, Hofman Y, Hendriks RW, Lubberts E (2014) Absence of interleukin-17 receptor A signaling prevents autoimmune inflammation of the joint and leads to a Th2-like phenotype in collagen-induced arthritis. Arthritis Rheumatol 66:340\u2013349. doi: 10.1002\/art.38229","journal-title":"Arthritis Rheumatol"},{"key":"3387_CR103","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.4049\/jimmunol.0901767","volume":"184","author":"D Pennino","year":"2010","unstructured":"Pennino D, Eyerich K, Scarponi C, Carbone T, Eyerich S, Nasorri F, Garcovich S, Traidl-Hoffmann C, Albanesi C, Cavani A (2010) IL17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes. J Immunol 184:4880\u20134888. doi: 10.4049\/jimmunol.0901767","journal-title":"J Immunol"},{"key":"3387_CR104","doi-asserted-by":"crossref","first-page":"e62231","DOI":"10.1371\/journal.pone.0062231","volume":"8","author":"M Katayama","year":"2013","unstructured":"Katayama M, Ohmura K, Yukawa N, Terao C, Hashimoto M, Yoshifuji H, Kawabata D, Fujii T, Iwakura Y, Mimori T (2013) Neutrophils are essential as a source of IL17 in the effector phase of arthritis. PLoS ONE 8:e62231. doi: 10.1371\/journal.pone.0062231","journal-title":"PLoS ONE"},{"key":"3387_CR105","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.4049\/jimmunol.0903566","volume":"184","author":"AJ Hueber","year":"2010","unstructured":"Hueber AJ, Asquith DL, Miller AM, Reilly J, Kerr S, Leipe J, Melendez AJ, McInnes IB (2010) Mast cells express IL17A in rheumatoid arthritis synovium. J Immunol 184:3336\u20133340. doi: 10.4049\/jimmunol.0903566","journal-title":"J Immunol"},{"key":"3387_CR106","doi-asserted-by":"crossref","first-page":"R150","DOI":"10.1186\/ar3466","volume":"13","author":"J Suurmond","year":"2011","unstructured":"Suurmond J, Dorj\u00e9e AL, Boon MR, Knol EF, Huizinga TWJ, Toes REM, Schuerwegh AJM (2011) Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium. Arthritis Res Ther 13:R150. doi: 10.1186\/ar3466","journal-title":"Arthritis Res Ther"},{"key":"3387_CR107","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/art.1780270802","volume":"27","author":"AJ Crisp","year":"1984","unstructured":"Crisp AJ, Chapman CM, Kirkham SE, Schiller AL, Krane SM (1984) Articular mastocytosis in rheumatoid arthritis. Arthritis Rheum 27:845\u2013851. doi: 10.1002\/art.1780270802","journal-title":"Arthritis Rheum"},{"key":"3387_CR108","first-page":"1326","volume":"15","author":"JA Kopicky-Burd","year":"1988","unstructured":"Kopicky-Burd JA, Kagey-Sobotka A, Peters SP, Dvorak AM, Lennox DW, Lichtenstein LM, Wigley FM (1988) Characterization of human synovial mast cells. J Rheumatol 15:1326\u20131333","journal-title":"J Rheumatol"},{"key":"3387_CR109","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/art.1780340907","volume":"34","author":"AJ Bridges","year":"1991","unstructured":"Bridges AJ, Malone DG, Jicinsky J, Chen M, Ory P, Engber W, Graziano FM (1991) Human synovial mast cell involvement in rheumatoid arthritis and osteoarthritis. Relationship to disease type, clinical activity, and antirheumatic therapy. Arthritis Rheum 34:1116\u20131124. doi: 10.1002\/art.1780340907","journal-title":"Arthritis Rheum"},{"key":"3387_CR110","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/art.1780400314","volume":"40","author":"I Gotis-Graham","year":"1997","unstructured":"Gotis-Graham I, McNeil HP (1997) Mast cell responses in rheumatoid synovium. Association of the MCTC subset with matrix turnover and clinical progression. Arthritis Rheum 40:479\u2013489. doi: 10.1002\/art.1780400314","journal-title":"Arthritis Rheum"},{"key":"3387_CR111","first-page":"2304","volume":"25","author":"A Ceponis","year":"1998","unstructured":"Ceponis A, Konttinen YT, Takagi M, Xu JW, Sorsa T, Matucci-Cerinic M, Santavirta S, Bankl HC, Valent P (1998) Expression of stem cell factor (SCF) and SCF receptor (c-kit) in synovial membrane in arthritis: correlation with synovial mast cell hyperplasia and inflammation. J Rheumatol 25:2304\u20132314","journal-title":"J Rheumatol"},{"key":"3387_CR112","first-page":"13","volume":"13","author":"DB Frewin","year":"1986","unstructured":"Frewin DB, Cleland LG, Jonsson JR, Robertson PW (1986) Histamine levels in human synovial fluid. J Rheumatol 13:13\u201314","journal-title":"J Rheumatol"},{"key":"3387_CR113","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/art.1780290803","volume":"29","author":"DG Malone","year":"1986","unstructured":"Malone DG, Irani AM, Schwartz LB, Barrett KE, Metcalfe DD (1986) Mast cell numbers and histamine levels in synovial fluids from patients with diverse arthritides. Arthritis Rheum 29:956\u2013963. doi: 10.1002\/art.1780290803","journal-title":"Arthritis Rheum"},{"key":"3387_CR114","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1042\/cs0930363","volume":"93","author":"MG Buckley","year":"1997","unstructured":"Buckley MG, Walters C, Wong WM, Cawley MI, Ren S, Schwartz LB, Walls AF (1997) Mast cell activation in arthritis: detection of alpha- and beta-tryptase, histamine and eosinophil cationic protein in synovial fluid. Clin Sci (Lond) 93:363\u2013370. doi: 10.1042\/cs0930363","journal-title":"Clin Sci (Lond)"},{"key":"3387_CR115","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/art.1780341209","volume":"34","author":"JP Brodeur","year":"1991","unstructured":"Brodeur JP, Ruddy S, Schwartz LB, Moxley G (1991) Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis. Arthritis Rheum 34:1531\u20131537. doi: 10.1002\/art.1780341209","journal-title":"Arthritis Rheum"},{"key":"3387_CR116","first-page":"425","volume":"72","author":"JP Lavery","year":"1994","unstructured":"Lavery JP, Lisse JR (1994) Preliminary study of the tryptase levels in the synovial fluid of patients with inflammatory arthritis. Ann Allergy 72:425\u2013427","journal-title":"Ann Allergy"},{"key":"3387_CR117","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/imm.12197","volume":"142","author":"Y Guo","year":"2014","unstructured":"Guo Y, Wu Q, Ni B, Mou Z, Jiang Q, Cao Y, Dong H, Wu Y (2014) Tryptase is a candidate autoantigen in rheumatoid arthritis. Immunology 142:67\u201377. doi: 10.1111\/imm.12197","journal-title":"Immunology"},{"key":"3387_CR118","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bone.2011.07.004","volume":"49","author":"M Rossini","year":"2011","unstructured":"Rossini M, Zanotti R, Bonadonna P, Artuso A, Caruso B, Schena D, Vecchiato D, Bonifacio M, Viapiana O, Gatti D, Senna G, Riccio A, Passalacqua G, Pizzolo G, Adami S (2011) Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis. Bone 49:880\u2013885. doi: 10.1016\/j.bone.2011.07.004","journal-title":"Bone"},{"key":"3387_CR119","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.iac.2014.01.011","volume":"34","author":"M Rossini","year":"2014","unstructured":"Rossini M, Zanotti R, Viapiana O, Tripi G, Orsolini G, Idolazzi L, Bonadonna P, Schena D, Escribano L, Adami S, Gatti D (2014) Bone involvement and osteoporosis in mastocytosis. Immunol Allergy Clin North Am 34:383\u2013396. doi: 10.1016\/j.iac.2014.01.011","journal-title":"Immunol Allergy Clin North Am"},{"key":"3387_CR120","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.semarthrit.2014.05.016","volume":"44","author":"B Bader-Meunier","year":"2014","unstructured":"Bader-Meunier B, Bulai Livideanu C, Larroche C et al (2014) Association of mastocytosis with inflammatory joint diseases: a series of 31 patients. Semin Arthritis Rheum 44:362\u2013365. doi: 10.1016\/j.semarthrit.2014.05.016","journal-title":"Semin Arthritis Rheum"},{"key":"3387_CR121","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.4049\/jimmunol.170.9.4432","volume":"170","author":"KI Happel","year":"2003","unstructured":"Happel KI, Zheng M, Young E, Quinton LJ, Lockhart E, Ramsay AJ, Shellito JE, Schurr JR, Bagby GJ, Nelson S, Kolls JK (2003) Cutting edge: roles of Toll-like receptor 4 and IL 23 in IL 17 expression in response to Klebsiella pneumonia infection. J Immunol 170:4432\u20134436. doi: 10.4049\/jimmunol.170.9.4432","journal-title":"J Immunol"},{"key":"3387_CR122","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","volume":"31","author":"C Sutton","year":"2009","unstructured":"Sutton C, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KHG (2009) Interleukin 1 and IL 23 induce innate IL 17 production from \u03b3\u03b4 T cells, amplifying TH17 responses and autoimmunity. Immunity 31:331\u2013341. doi: 10.1016\/j.immuni.2009.08.001","journal-title":"Immunity"},{"key":"3387_CR123","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.4049\/jimmunol.180.8.5167","volume":"180","author":"AV Rachitskaya","year":"2008","unstructured":"Rachitskaya AV, Hansen AM, Horai R, Li Z, Villasmil R, Luger D, Nussenblatt RB, Caspi RR (2008) Cutting edge: NKT cells constitutively express IL 23 receptor and ROR\u03b3t and rapidly produce IL 17 upon receptor ligation in an IL 6 independent fashion. J Immunol 180:5167\u20135171. doi: 10.4049\/jimmunol.180.8.5167","journal-title":"J Immunol"},{"key":"3387_CR124","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.4049\/jimmunol.1003370","volume":"186","author":"B P\u00f6llinger","year":"2011","unstructured":"P\u00f6llinger B, Junt T, Metzler B, Walker UA, Tyndall A, Allard C, Bay S, Keller R, Raulf F, Di Padova F, O\u2019Reilly T, Horwood NJ, Patel DD, Littlewood-Evans A (2011) TH17 cells, not IL 17\u00a0+\u00a0\u03b3\u03b4 T cells, drive arthritic bone destruction in mice and humans. J Immunol 186:2602\u20132612. doi: 10.4049\/jimmunol.1003370","journal-title":"J Immunol"},{"key":"3387_CR125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00223-013-9750-6","volume":"93","author":"M Rossini","year":"2013","unstructured":"Rossini M, Adami S, Viapiana O, Tripi G, Zanotti R, Ortolani R, Vella A, Troplini S, Gatti D (2013) Acute phase response after zoledronic acid is associated with long-term effects on white blood cells. Calcif Tissue Int 93:249\u2013252. doi: 10.1007\/s00223-013-9750-6","journal-title":"Calcif Tissue Int"},{"key":"3387_CR126","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/rheumatology\/ket321","volume":"53","author":"O Viapiana","year":"2014","unstructured":"Viapiana O, Gatti D, Idolazzi L, Fracassi E, Adami S, Troplini S, Povino MR, Rossini M (2014) Bisphosphonates vs infliximab in ankylosing spondylitis treatment. Rheumatology (Oxford) 53:90\u201394. doi: 10.1093\/rheumatology\/ket321","journal-title":"Rheumatology (Oxford)"},{"key":"3387_CR127","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrrheum.2010.173","volume":"7","author":"CG Borrero","year":"2011","unstructured":"Borrero CG, Mountz JM, Mountz JD (2011) Emerging MRI methods in rheumatoid arthritis. Nat Rev Rheumatol 7:85\u201395. doi: 10.1038\/nrrheum.2010.173","journal-title":"Nat Rev Rheumatol"},{"key":"3387_CR128","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/art.23546","volume":"58","author":"ST Proulx","year":"2008","unstructured":"Proulx ST, Kwok E, You Z, Papuga MO, Beck CA, Shealy DJ, Calvi LM, Ritchlin CT, Awad HA, Boyce BF, Xing L, Schwarz EM (2008) Elucidating bone marrow edema and myelopoiesis in murine arthritis using contrast-enhanced magnetic resonance imaging. Arthritis Rheum 58:2019\u20132029. doi: 10.1002\/art.23546","journal-title":"Arthritis Rheum"},{"key":"3387_CR129","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/ard.2009.119156","volume":"69","author":"C Lukas","year":"2010","unstructured":"Lukas C, van der Heijde D, Fatenejad S, Landew\u00e9 R (2010) Repair of erosions occurs almost exclusively in damaged joints without swelling. Ann Rheum Dis 69:851\u2013855. doi: 10.1136\/ard.2009.119156","journal-title":"Ann Rheum Dis"},{"key":"3387_CR130","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1136\/ard.2008.097048","volume":"68","author":"U M\u00f8ller D\u00f8hn","year":"2009","unstructured":"M\u00f8ller D\u00f8hn U, Boonen A, Hetland ML, Hansen MS, Knudsen LS, Hansen A, Madsen OR, Hasselquist M, M\u00f8ller JM, \u00d8stergaard M (2009) Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1-year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure. Ann Rheum Dis 68:1585\u20131590. doi: 10.1136\/ard.2008.097048","journal-title":"Ann Rheum Dis"},{"key":"3387_CR131","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.33504","volume":"64","author":"MM Matzelle","year":"2012","unstructured":"Matzelle MM, Gallant MA, Condon KW, Walsh NC, Manning CA, Stein GS, Lian JB, Burr DB, Gravallese EM (2012) Resolution of inflammation induces OB function and regulates the Wnt signaling pathway. Arthritis Rheum 64:1540\u20131550. doi: 10.1002\/art.33504","journal-title":"Arthritis Rheum"},{"key":"3387_CR132","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1002\/art.23945","volume":"58","author":"AK Brown","year":"2008","unstructured":"Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, Hensor E, Wakefield RJ, O\u2019Connor PJ, Emery P (2008) An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 58:2958\u20132967. doi: 10.1002\/art.23945","journal-title":"Arthritis Rheum"},{"key":"3387_CR133","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1359\/jbmr.090320","volume":"24","author":"NC Walsh","year":"2009","unstructured":"Walsh NC, Reinwald S, Manning CA, Condon KW, Iwata K, Burr DB, Gravallese EM (2009) OB function is compromised at sites of focal bone erosion in inflammatory arthritis. J Bone Miner Res 24:1572\u20131585. doi: 10.1359\/jbmr.090320","journal-title":"J Bone Miner Res"},{"key":"3387_CR134","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.bone.2008.12.006","volume":"44","author":"FP Luyten","year":"2009","unstructured":"Luyten FP, Tylzanowski P, Lories RJ (2009) Wnt signaling and osteoarthritis. Bone 44:522\u2013527. doi: 10.1016\/j.bone.2008.12.006","journal-title":"Bone"},{"key":"3387_CR135","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1002\/art.24888","volume":"60","author":"H Appel","year":"2009","unstructured":"Appel H, Ruiz-Heiland G, Listing J, Zwerina J, Herrmann M, Mueller R, Haibel H, Baraliakos X, Hempfing A, Rudwaleit M, Sieper J, Schett G (2009) Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum 60:3257\u20133562. doi: 10.1002\/art.24888","journal-title":"Arthritis Rheum"},{"key":"3387_CR136","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1007\/s00296-011-1981-0","volume":"32","author":"SR Kwon","year":"2012","unstructured":"Kwon SR, Lim MJ, Suh CH, Park SG, Hong YS, Yoon BY, Kim HA, Choi HJ, Park W (2012) Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy. Rheumatol Int 32:2523\u20132527. doi: 10.1007\/s00296-011-1981-0","journal-title":"Rheumatol Int"},{"key":"3387_CR137","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/art.27231","volume":"62","author":"D Daoussis","year":"2010","unstructured":"Daoussis D, Liossis SN, Solomou EE, Tsanaktsi A, Bounia K, Karampetsou M, Yiannopoulos G, Andonopoulos AP (2010) Evidence that Dkk 1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum 62:150\u2013158. doi: 10.1002\/art.27231","journal-title":"Arthritis Rheum"},{"key":"3387_CR138","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/annrheumdis-2011-200216","volume":"71","author":"GR Heiland","year":"2012","unstructured":"Heiland GR, Appel H, Poddubnyy D, Zwerina J, Hueber A, Haibel H, Baraliakos X, Listing J, Rudwaleit M, Schett G, Sieper J (2012) High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis. Ann Rheum Dis 71:572\u2013574. doi: 10.1136\/annrheumdis-2011-200216","journal-title":"Ann Rheum Dis"},{"key":"3387_CR139","first-page":"77","volume":"33","author":"M Rossini","year":"2015","unstructured":"Rossini M, Viapiana O, Adami S, Fracassi E, Idolazzi L, Dartizio C, Povino MR, Orsolini G, Gatti D (2015) In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density. Clin Exp Rheumatol 33:77\u201383","journal-title":"Clin Exp Rheumatol"},{"key":"3387_CR140","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrrheum.2011.156","volume":"7","author":"R Lories","year":"2011","unstructured":"Lories R (2011) The balance of tissue repair and remodeling in chronic arthritis. Nat Rev Rheumatol 7:700\u2013707. doi: 10.1038\/nrrheum.2011.156","journal-title":"Nat Rev Rheumatol"},{"key":"3387_CR141","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3899\/jrheum.140173","volume":"41","author":"G Schett","year":"2014","unstructured":"Schett G (2014) Bone formation in psoriatic arthritis: a report from the GRAPPA 2013 annual meeting. J Rheumatol 41:1218\u20131219. doi: 10.3899\/jrheum.140173","journal-title":"J Rheumatol"},{"key":"3387_CR142","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1002\/art.22758","volume":"56","author":"D McGonagle","year":"2007","unstructured":"McGonagle D, Lories RJ, Tan AL, Benjamin M (2007) The concept of a \u2018\u2018synovio-entheseal complex\u2019\u2019 and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis Rheum 56:2482\u20132491. doi: 10.1002\/art.22758","journal-title":"Arthritis Rheum"},{"key":"3387_CR143","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.24132","volume":"60","author":"WP Maksymowych","year":"2009","unstructured":"Maksymowych WP, Chiowchanwisawakit P, Clare T, Pedersen SJ, \u00d8stergaard M, Lambert RG (2009) Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum 60:93\u2013102. doi: 10.1002\/art.24132","journal-title":"Arthritis Rheum"},{"key":"3387_CR144","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/rheumatology\/ket426","volume":"53","author":"RP Poggenborg","year":"2014","unstructured":"Poggenborg RP, Wiell C, B\u00f8yesen P, Boonen A, Bird P, Pedersen SJ, S\u00f8rensen IJ, Madsen OR, Slot O, M\u00f8ller JM, Hasselquist M, Kubassova O, \u00d8stergaard M (2014) No overall damage progression despite persistent inflammation in adalimumab-treated psoriatic arthritis patients: results from an investigator-initiated 48-week comparative magnetic resonance imaging, computed tomography and radiography trial. Rheumatology (Oxford) 53:746\u2013756. doi: 10.1093\/rheumatology\/ket426","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"3387_CR145","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/ar2794","volume":"11","author":"D Heijde van der","year":"2009","unstructured":"van der Heijde D, Salonen D, Weissman BN, Landew\u00e9 R, Maksymowych WP, Kupper H, Ballal S, Gibson E, Wong R (2009) Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years. Arthritis Res Ther 11(4):R127. doi: 10.1186\/ar2794","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"3387_CR146","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.23471","volume":"58","author":"D Heijde van der","year":"2008","unstructured":"van der Heijde D, Landew\u00e9 R, Einstein S, Ory P, Vosse D, Ni L, Lin SL, Tsuji W, Davis JC Jr (2008) Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum 58(5):1324\u20131331. doi: 10.1002\/art.23471","journal-title":"Arthritis Rheum"},{"issue":"10","key":"3387_CR147","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1002\/art.23901","volume":"58","author":"D Heijde van der","year":"2008","unstructured":"van der Heijde D, Landew\u00e9 R, Baraliakos X, Houben H, van Tubergen A, Williamson P, Xu W, Baker D, Goldstein N, Braun J (2008) Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum 58(10):3063\u20133070. doi: 10.1002\/art.23901","journal-title":"Arthritis Rheum"},{"issue":"10","key":"3387_CR148","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.38070","volume":"65","author":"N Haroon","year":"2013","unstructured":"Haroon N, Inman RD, Learch TJ, Weisman MH, Lee M, Rahbar MH, Ward MM, Reveille JD, Gensler LS (2013) The impact of tumor necrosis factor \u03b1 inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum 65(10):2645\u20132654. doi: 10.1002\/art.38070","journal-title":"Arthritis Rheum"},{"issue":"4","key":"3387_CR149","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/BOR.0000000000000077","volume":"26","author":"N Haroon","year":"2014","unstructured":"Haroon N (2014) The effect of tumor necrosis factor-blockade on new bone formation in ankylosing spondylitis: what is the evidence? Curr Opin Rheumatol 26(4):389\u2013394. doi: 10.1097\/BOR.0000000000000077","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"3387_CR150","first-page":"281","volume":"74","author":"X Baraliakos","year":"2015","unstructured":"Baraliakos X, Braun J, Sieper J, Baeten DL, Readie A, Ligozio G, Richards H (2015) Secukinumab reduces sacroiliac joint and spinal inflammation in patients with ankylosing spondylitis: MRI data from a phase 3 randomised, double-blind, placebo-controlled study. Ann Rheum Dis 74(2):281","journal-title":"Ann Rheum Dis"},{"key":"3387_CR151","doi-asserted-by":"crossref","first-page":"S424","DOI":"10.1002\/acr.22122","volume":"66","author":"D Heijde van der","year":"2014","unstructured":"van der Heijde D, Landew\u00e9 RBM, Mease PJ, McInnes IB, Conaghan PG, Pricop L, Ligozio G, Richards H, Mpofu S (2014) Secukinumab, a monoclonal antibody to interleukin-17A, provides significant and sustained inhibition of joint structural damage in active psoriatic arthritis regardless of prior TNF inhibitors or concomitant methotrexate: a phase 3 randomized, double-blind, placebo-controlled study. Arthritis Rheum 66:S424","journal-title":"Arthritis Rheum"},{"key":"3387_CR152","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/rheumatology\/kes384","volume":"52","author":"AL Tan","year":"2013","unstructured":"Tan AL, Tanner SF, Waller ML, Hensor EM, Burns A, Jeavons AP, Bury RF, Emery P, McGonagle D (2013) High-resolution [18F]fluoride positron emission tomography of the distal interphalangeal joint in psoriatic arthritis\u2013a bone-enthesis-nail complex. Rheumatology (Oxford) 52:898\u2013904. doi: 10.1093\/rheumatology\/kes384","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"3387_CR153","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1136\/annrheumdis-2015-eular.3789","volume":"74","author":"L Idolazzi","year":"2015","unstructured":"Idolazzi L, Vantaggiato E, Salgarello M, Perandini S, Fassio A, Povino MR, Fracassi E, Viapiana O, Gatti D, Rossini M, Adami S (2015) 18F-Fluoride PET\/CT for detection of axial involvement in ankylosing spondylitis. Ann Rheum Dis 74(2):1158. doi: 10.1136\/annrheumdis-2015-eular.3789","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-015-3387-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-015-3387-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-015-3387-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T07:46:27Z","timestamp":1748677587000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-015-3387-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,31]]},"references-count":153,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["3387"],"URL":"https:\/\/doi.org\/10.1007\/s00296-015-3387-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,31]]}}}